Pinworm infection and control among children living in Low Income Settlements in Colombo Municipal Council area
Phase 4
Recruiting
- Conditions
- Pin worm infection
- Registration Number
- SLCTR/2013/033
- Lead Sponsor
- Department of Public Health
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 1210
Inclusion Criteria
For randomization
1.Children aged completion of 3 years to completion of 7 years
2.Living in a low income settlement (LIS) for at least 1 year
For mass treatment and health education
1.Household members of the participants.
Exclusion Criteria
1. Any child with colostomy
2. Household members with contraindications to mebendazole will be excluded from the administration.
3. Pregnant women and children <2years will be excluded from mebendazole administration.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Mebendazole's efficacy against Enterobius vermicularis reinfection in pediatric populations?
How does mass Mebendazole treatment compare to standard anthelmintic therapies in reducing pinworm reinfection rates in low-income communities?
Are there specific biomarkers that can predict susceptibility to Enterobius vermicularis reinfection following mass deworming interventions?
What are the potential adverse events associated with Mebendazole mass administration in children aged 3-7 years in Sri Lanka?
What combination therapies or alternative anthelmintics show promise in controlling Enterobius vermicularis in resource-limited settings?